检出含量为0！百年老字号同仁堂 卷入造假风波

Core Viewpoint - The scandal surrounding Antarctic krill oil has highlighted the branding issues and quality control failures associated with Tongrentang, a well-known traditional Chinese medicine brand [2][4][11]. Group 1: Incident Overview - The Shanghai Consumer Protection Commission conducted tests on 15 popular Antarctic krill oil products, revealing that a product labeled as "Beijing Tongrentang 99% High Purity Antarctic Krill Oil" contained 0% phospholipid, indicating potential fraud [2][5]. - The implicated product was not directly produced by Beijing Tongrentang but was distributed by its subsidiary, Sichuan Health Pharmaceutical Co., Ltd., with manufacturing outsourced to Anhui Habio Pharmaceutical Co., Ltd., exemplifying a typical private label model [2][4]. - Following the investigation, both the distributor and manufacturer were summoned by the Shanghai Consumer Protection Commission, with Habio admitting to not including the claimed Antarctic krill oil in the production process [6][8]. Group 2: Brand Trust Crisis - Beijing Tongrentang, established in 1669, has faced multiple trust crises due to private label issues, leading to concerns about its brand management and quality control [4][11]. - The Antarctic krill oil market has seen a surge in popularity, but the wide price range and varying quality have made it difficult for consumers to discern reliable products [5][11]. - Experts suggest that the brand's response, which includes legal action against the involved companies and a reminder for consumers to verify the authenticity of the "Double Dragon" trademark, may not fully alleviate public skepticism [9][11]. Group 3: Regulatory and Compliance Issues - The Shanghai Consumer Protection Commission has urged Sichuan Health Pharmaceutical to conduct a self-examination, apologize to consumers, and recall the problematic products [8][12]. - The incident has raised questions about the accountability of Beijing Tongrentang regarding its subsidiaries and the need for clearer brand management and authorization boundaries [11][12]. - Experts recommend that Beijing Tongrentang establish a comprehensive quality control and traceability system to prevent future issues, including stricter oversight of its subsidiaries and private label products [13][15]. Group 4: Manufacturer's Legal Troubles - Anhui Habio Pharmaceutical, the manufacturer of the disputed krill oil, has been involved in multiple legal disputes, including trademark infringement cases, indicating a pattern of compliance issues [14][15]. - The company has faced administrative penalties for various violations, highlighting the need for a robust compliance framework to ensure product quality and legal adherence [15].